Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk by 42% in Phase 3 Trial
Phase 3 trial results presented at ESMO 2026 show that adding personalized mRNA vaccine intismeran to pembrolizumab reduces melanoma recurrence ...
Tag: Immunotherapy
Phase 3 Trial: New Drug Cuts Endometrial Cancer Death Risk
A phase 3 trial shows sacituzumab tirumotecan significantly lowers the risk of cancer progression and death in women with recurrent ...
Early Immunotherapy May Spare Some Breast Cancer Patients Chemo
Triple-negative breast cancer represents a particularly aggressive subtype of the disease, characterized by the absence of hormone receptors and HER2 ...
Eight-Gene Signature Ties Immune Landscape to Gastric Cancer Survival
An integrated transcriptomic and tissue-level study links an eight-gene risk score and the immune regulator RGS1 to survival in gastric ...
Class III BRAF alterations linked to shorter survival in metastatic NSCLC
A retrospective multicenter study linked class III BRAF alterations in metastatic NSCLC to shorter overall survival and distinct co-mutation patterns ...
MD Anderson and Nature to host conference on next-generation cancer therapies
A three-day 2026 conference in Houston will examine emerging cancer therapeutics, targeted protein modulation, immunotherapies and artificial intelligence in drug ...
Retrospective study finds multimodal AI improves immunotherapy outcome prediction in advanced lung cancer
In a retrospective I3LUNG study of 2,396 patients, multimodal AI outperformed standard clinical biomarkers for survival-outcome prediction, and AI support ...
Study Reveals How p53-Mutant Tumors Hide From T Cells
A Dana-Farber-led Immunity study shows that p53-mutant cancers can evade T-cell detection through several mechanisms, while laboratory ERAP1 inhibition restores ...
Single case links delayed fatal TEN to urothelial cancer combination therapy
A single-patient case report documents delayed toxic epidermal necrolysis after six cycles of pembrolizumab and enfortumab vedotin for metastatic urothelial ...
Observational study refines relapse risk after blinatumomab in childhood leukemia
An observational study of more than 200 children and young people found that early response to blinatumomab and leukemia genetics ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!